<DOC>
	<DOCNO>NCT01812174</DOCNO>
	<brief_summary>This study examine hemodynamic hemolytic property two additional small size valve On-X line valve already approve FDA .</brief_summary>
	<brief_title>On-X Heart Valve - 17mm Aortic 23mm Mitral</brief_title>
	<detailed_description>The purpose study assess safety efficacy 17mm On-X Aortic Prosthetic Heart Valve 23mm On-X Mitral Prosthetic Heart Valve use replace diseased mitral valve human subject . The On-X 17mm aortic 23mm mitral valve implant approximately 20 least 15 patient per size follow least 1 year . Patients age require size valve determine surgery recruit prior surgery base result preoperative screening test .</detailed_description>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>1 . Patients age , assent patient consent parent authorized legal representative require patient age majority legally emancipate . 2 . Patients sufficiently ill warrant replacement diseased natural prosthetic valve , base standard cardiovascular diagnostic workups . 3 . Patients sufficient satisfactory condition , base physical exam investigator 's experience , average well operative risk , ( i.e. , likely survive one year postoperatively ) . 4 . Patients require isolated aortic valve replacement size 17 mm isolate mitral valve replacement size 23mm . 5 . Patients geographically stable willing return implant center followup visit . 6 . Patients adequately informed participation clinical study require order comply protocol . 7 . Patients require concomitant cardiovascular surgery , coronary bypass may include study . 1 . Patients pregnant , plan become pregnant lactating . 2 Patients noncardiac progressive disease , investigator 's experience produce unacceptable increase risk patient . 3 Patients documented history substance ( drug alcohol ) abuser prison inmate . 4 . Patients previous prosthetic valve , replace study valve , patient require multiple valve replacement . 5 . Patients active endocarditis active myocarditis . 6 Patients require tricuspid pulmonic valve replacement . 7 . Patients agree return require number followup visit geographically unavailable followup . 8 . Patients maintain longterm anticoagulant therapy . 9 . Patients noncardiac illness result life expectancy less 1year . 10 . Patients previously enrol implanted trial may reenter withdrawal . 11 . Patients already enrol another investigational device drug study ( enrolled patient enrolled study ) . 12 . Patients acute preoperative neurological deficit , myocardial infarction , cardiac event return baseline least 30days prior enrollment . 13 . Patients aortic aneurysm medical condition create high usual risk surgical complication . 14 . Patients prisoner mentally ill , pediatric patient incapable understanding assent judge principal investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>heart valve</keyword>
</DOC>